Market Overview:
The global cholesterol screening/cholesterol lab testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of obesity and other lifestyle diseases, growing geriatric population, and rising demand for early diagnosis and treatment. The global cholesterol screening/cholesterol lab testing market is segmented by type, application, and region. By type, the market is divided into hospital-based laboratories, clinical laboratories, and other laboratories. By application, the market is classified into physicians/providers and hospitals; employers; health plans and managed care organizations (MCOs); government agencies; patients; research institutes & contract research organizations (CROs); pharmaceutical & biotechnology companies; medical device manufacturers; academic institutions & teaching hospitals; public health departments & not-for-profit organizations. Geographically, the global cholesterol screening/cholesterol lab testing market spans North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U.K.), Asia Pacific (Japan China India Australia South Korea) Middle East Africa).
Product Definition:
A cholesterol screening is a blood test that measures the levels of cholesterol in your blood. Cholesterol lab testing is used to diagnose and monitor high cholesterol, a condition that can lead to heart disease.
Hospital:
Hospital is the primary testing location for patients with cholesterol related problems. It also serves as a backup for those who cannot afford or are unwilling to undergo tests at other facilities. The hospital provides cholesterol screening and lab testing services to all its patients, regardless of their ability to pay.
The number of people suffering from high blood pressure, diabetes.
Clinical Laboratories:
A clinical laboratory is a facility that provides diagnostic testing for medical conditions. The most common tests performed in clinical laboratories are blood glucose testing, cholesterol testing, and Hb1Ac Testing.
Application Insights:
The physicians/ providers segment dominated the global cholesterol screening/ cholesterol lab testing market in 2017. This can be attributed to factors such as increasing awareness about preventive healthcare and rising incidences of cardiovascular diseases. As per the National Center for Biotechnology Information (NCBI) in 2016, around 1 death in 3 is caused by Cardiovascular Diseases (CVDs) globally, which is expected to rise to 2 deaths in 3 by 2030. Thus, preventive measures are considered necessary to reduce the incidence rate of CVDs.
Regional Analysis:
North America dominated the global cholesterol screening/cholesterol lab testing market in 2017. This can be attributed to the presence of sophisticated healthcare infrastructure, high awareness levels coupled with a large patient pool at risk for developing cardiovascular diseases (CVDs). Moreover, initiatives undertaken by government bodies and private organizations to create awareness regarding cholesterol screening are also responsible for its largest share. For instance, as part of their ongoing efforts aimed at reducing CVDs in North America, The American Heart Association (AHA) along with other like-minded organizations have been conducting various programs and activities such asâ€Go Red For Womenâ€and “Men Can Stop Stroke Too†campaigns that raise awareness about heart health among women and men respectively.
Growth Factors:
- Increasing incidence of lifestyle diseases such as obesity and diabetes, which are major risk factors for developing cardiovascular diseases (CVDs), is expected to drive the demand for cholesterol screening and cholesterol lab testing services.
- Growing awareness about the importance of early diagnosis and treatment of CVDs is anticipated to boost the market growth.
- Rising geriatric population is another key factor that will propel the demand for cholesterol screening services in near future.
- Technological advancements in diagnostic methods are likely to create new opportunities for market players operating in this space over the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Cholesterol Screening/ Cholesterol Lab Testing Market Research Report
By Type
Hospital, Clinical Laboratories, Other
By Application
Physicians/Providers and Hospitals, Employers, Health Plans and Managed Care Organizations(MCOs), Government Agencies, Patients
By Companies
Laboratory Corporation of America Holdings, Quest Diagnostics, Eurofins Scientific, Spectra Laboratories, Unilabs, Synlab International, Bio-Reference Laboratories, Clinical Reference Laboratory, ACM Medical Laboratory, Adicon Clinical Laboratory
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Cholesterol Screening/ Cholesterol Lab Testing Market Report Segments:
The global Cholesterol Screening/ Cholesterol Lab Testing market is segmented on the basis of:
Types
Hospital, Clinical Laboratories, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Physicians/Providers and Hospitals, Employers, Health Plans and Managed Care Organizations(MCOs), Government Agencies, Patients
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Laboratory Corporation of America Holdings
- Quest Diagnostics
- Eurofins Scientific
- Spectra Laboratories
- Unilabs
- Synlab International
- Bio-Reference Laboratories
- Clinical Reference Laboratory
- ACM Medical Laboratory
- Adicon Clinical Laboratory
Highlights of The Cholesterol Screening/ Cholesterol Lab Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hospital
- Clinical Laboratories
- Other
- By Application:
- Physicians/Providers and Hospitals
- Employers, Health Plans and Managed Care Organizations(MCOs)
- Government Agencies
- Patients
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cholesterol Screening/ Cholesterol Lab Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cholesterol screening is a blood test that measures the level of cholesterol in your blood. A cholesterol lab test checks for different types of cholesterol in your bloodstream.
Some of the major companies in the cholesterol screening/ cholesterol lab testing market are Laboratory Corporation of America Holdings, Quest Diagnostics, Eurofins Scientific, Spectra Laboratories, Unilabs, Synlab International, Bio-Reference Laboratories, Clinical Reference Laboratory, ACM Medical Laboratory, Adicon Clinical Laboratory.
The cholesterol screening/ cholesterol lab testing market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cholesterol Screening/ Cholesterol Lab Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cholesterol Screening/ Cholesterol Lab Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cholesterol Screening/ Cholesterol Lab Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cholesterol Screening/ Cholesterol Lab Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cholesterol Screening/ Cholesterol Lab Testing Market Size & Forecast, 2020-2028
4.5.1 Cholesterol Screening/ Cholesterol Lab Testing Market Size and Y-o-Y Growth
4.5.2 Cholesterol Screening/ Cholesterol Lab Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Hospital
5.2.2 Clinical Laboratories
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Physicians/Providers and Hospitals
6.2.2 Employers
6.2.3 Health Plans and Managed Care Organizations(MCOs)
6.2.4 Government Agencies
6.2.5 Patients
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cholesterol Screening/ Cholesterol Lab Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cholesterol Screening/ Cholesterol Lab Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Hospital
9.6.2 Clinical Laboratories
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Physicians/Providers and Hospitals
9.10.2 Employers
9.10.3 Health Plans and Managed Care Organizations(MCOs)
9.10.4 Government Agencies
9.10.5 Patients
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Hospital
10.6.2 Clinical Laboratories
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Physicians/Providers and Hospitals
10.10.2 Employers
10.10.3 Health Plans and Managed Care Organizations(MCOs)
10.10.4 Government Agencies
10.10.5 Patients
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Hospital
11.6.2 Clinical Laboratories
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Physicians/Providers and Hospitals
11.10.2 Employers
11.10.3 Health Plans and Managed Care Organizations(MCOs)
11.10.4 Government Agencies
11.10.5 Patients
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Hospital
12.6.2 Clinical Laboratories
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Physicians/Providers and Hospitals
12.10.2 Employers
12.10.3 Health Plans and Managed Care Organizations(MCOs)
12.10.4 Government Agencies
12.10.5 Patients
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Hospital
13.6.2 Clinical Laboratories
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Physicians/Providers and Hospitals
13.10.2 Employers
13.10.3 Health Plans and Managed Care Organizations(MCOs)
13.10.4 Government Agencies
13.10.5 Patients
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cholesterol Screening/ Cholesterol Lab Testing Market: Competitive Dashboard
14.2 Global Cholesterol Screening/ Cholesterol Lab Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Laboratory Corporation of America Holdings
14.3.2 Quest Diagnostics
14.3.3 Eurofins Scientific
14.3.4 Spectra Laboratories
14.3.5 Unilabs
14.3.6 Synlab International
14.3.7 Bio-Reference Laboratories
14.3.8 Clinical Reference Laboratory
14.3.9 ACM Medical Laboratory
14.3.10 Adicon Clinical Laboratory
